FDA Warns Type 2 Diabetes Medications May Cause Severe Joint Pain

Article

Health care professionals advised to discontinue drug regimen when appropriate.

Health care professionals advised to discontinue drug regimen when appropriate.

The FDA recently issued a warning for the type 2 diabetes treatments sitagliptin, saxagliptin, linagliptin, and alogliptin due to severe joint pain experienced by some users.

The joint pain can be severe and disabling, therefore caregivers should monitor these conditions. The FDA issued a new Warning and Precaution about this risk to the labels of all medications within the drug class dipeptidyl peptidase-4 (DPP-4) inhibitors.

DPP-4 inhibitors are used along with diet and exercise to lower blood sugar in adults with type 2 diabetes, a condition that can lead to blindness, nerve and kidney damage, and heart disease when left untreated.

Patients who experience joint pain from the medications indicated above should not discontinue their medication. They are advised to contact their treating physician and report the problem to the

FDA’s MedWatch Safety Information and Adverse Event Reporting Program.

Health care professionals are advised to discontinue the medication if it seems appropriate to do so.

Related Videos
Pharmacist holding medicine box in pharmacy drugstore. | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Drugstore Checkout Cashier Counter | Image Credit: Gorodenkoff - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
Biosimilar pharmaceutical drug bottle on blue background. | Image Credit: Carl - stock.adobe.com
Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line. | Image Credit: wacomka - stock.adobe.com
Bottle and scattered pills on color background, top view | Image Credit: New Africa - stock.adobe.com
pharmacy | Image Credit: Diego Cervo - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.